Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S G Potkin

Showing results (21-30 of 128) with videos related to

Pageof 13
Sort By:
DICP : the Annals of Pharmacotherapy|January 1, 1990
Patterns of neuroleptic usage in continuously hospitalized chronic schizophrenic patients: evidence for development of drug toleranceJ J Sramek, V Gaurano, J M Herrera, et al.
The American Journal of Psychiatry|January 1, 1983
Low CSF 5-hydroxyindoleacetic acid in schizophrenic patients with enlarged cerebral ventriclesS G Potkin, D R Weinberger, M Linnoila, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 18, 2006
Three-month change in cerebral glucose metabolism in patients with nonarteritic ischemic optic neuropathyS Bose, A C Mok, J H Fallon, et al.
Journal of Clinical Psychopharmacology|February 1, 1990
An open trial of glycine as an adjunct to neuroleptics in chronic treatment-refractory schizophrenicsJ Costa, E Khaled, J Sramek, et al.
The American Journal of Psychiatry|September 1, 1988
S-adenosylmethionine treatment of depression: a controlled clinical trialK M Bell, L Plon, W E Bunney, et al.
The American Journal of Psychiatry|October 1, 1988
Depression associated with nifedipine-induced calcium channel blockadeF J Hullett, S G Potkin, A B Levy, et al.
The American Journal of Psychiatry|January 19, 1999
Effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophreniaS G Potkin, Y Jin, B G Bunney, et al.
The Journal of Nervous and Mental Disease|January 1, 1977
Suicide prevention centers. Ecological study of effectivenessT P Bridge, S G Potkin, W W Zung, et al.
The New England Journal of Medicine|January 12, 1978
Are paranoid schizophrenics biologically different from other schizophrenics?S G Potkin, H E Cannon, D L Murphy, et al.
Psychiatry Research|October 1, 1979
Platelet monoamine oxidase: studies on the rate of heat inactivation in normal and in paranoid and nonparanoid chronic schizophrenic groupsC D Wise, T P Bridge, S G Potkin, et al.
Pageof 13

Showing results (21-30 of 128) with videos related to

Sort By:
Pageof 13
DICP : the Annals of Pharmacotherapy|January 1, 1990
Patterns of neuroleptic usage in continuously hospitalized chronic schizophrenic patients: evidence for development of drug toleranceJ J Sramek, V Gaurano, J M Herrera, et al.
The American Journal of Psychiatry|January 1, 1983
Low CSF 5-hydroxyindoleacetic acid in schizophrenic patients with enlarged cerebral ventriclesS G Potkin, D R Weinberger, M Linnoila, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 18, 2006
Three-month change in cerebral glucose metabolism in patients with nonarteritic ischemic optic neuropathyS Bose, A C Mok, J H Fallon, et al.
Journal of Clinical Psychopharmacology|February 1, 1990
An open trial of glycine as an adjunct to neuroleptics in chronic treatment-refractory schizophrenicsJ Costa, E Khaled, J Sramek, et al.
The American Journal of Psychiatry|September 1, 1988
S-adenosylmethionine treatment of depression: a controlled clinical trialK M Bell, L Plon, W E Bunney, et al.
The American Journal of Psychiatry|October 1, 1988
Depression associated with nifedipine-induced calcium channel blockadeF J Hullett, S G Potkin, A B Levy, et al.
The American Journal of Psychiatry|January 19, 1999
Effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophreniaS G Potkin, Y Jin, B G Bunney, et al.
The Journal of Nervous and Mental Disease|January 1, 1977
Suicide prevention centers. Ecological study of effectivenessT P Bridge, S G Potkin, W W Zung, et al.
The New England Journal of Medicine|January 12, 1978
Are paranoid schizophrenics biologically different from other schizophrenics?S G Potkin, H E Cannon, D L Murphy, et al.
Psychiatry Research|October 1, 1979
Platelet monoamine oxidase: studies on the rate of heat inactivation in normal and in paranoid and nonparanoid chronic schizophrenic groupsC D Wise, T P Bridge, S G Potkin, et al.
Pageof 13